Two wild weeks for Grail end in $8B Il­lu­mi­na buy­out

Grail’s whirl­wind two weeks have end­ed in the wealthy arms of its for­mer founder and bene­fac­tors.

Il­lu­mi­na has shelled out $8 bil­lion to reac­quire the close­ly-watched liq­uid biop­sy start­up they spun out just 5 years ago and sold off much of its shares just 3 years ago. The deal comes near­ly two weeks af­ter the well-heeled start­up filed for a po­ten­tial­ly mas­sive IPO — one that was dis­rupt­ed just a week lat­er when Bloomberg re­port­ed that Il­lu­mi­na was in talks to buy their for­mer spin­out for up to $8 bil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.